AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
LOSARTAN POTASSIUM / HYDROCHLOROTHIAZIDE in Rwanda
4 products registered with RDA — 2 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| COLOSAR-DENK 50/12.5 FILM COATED TABLETS | Rwanda FDA-HMP-MA-2304 | DENK PHARMA GmbH & Co. KG | active | 11 May 2030 |
| LOSARZED-H Tablets | Rwanda FDA-HMP-MA-2124 | Zota Healthcare Ltd | active | 17 Oct 2029 |
| LOSACAR-H 50/12.5 Tablets | Rwanda FDA-HMP-MA-0060 | CADILA HEALTHCARE LTD | expired | 1 Jun 2026 |
| LOSACAR-H 100/25 Tablets | Rwanda FDA-HMP-MA-0061 | CADILA HEALTHCARE LTD | expired | 1 Jun 2026 |
LOSARTAN POTASSIUM / HYDROCHLOROTHIAZIDE — RDA Registration Details
RDA (Rwanda) has 4 registered products containing LOSARTAN POTASSIUM / HYDROCHLOROTHIAZIDE, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track LOSARTAN POTASSIUM / HYDROCHLOROTHIAZIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.